These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34115851)

  • 1. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo.
    Walsh JH; Maddison KJ; Rankin T; Murray K; McArdle N; Ree MJ; Hillman DR; Eastwood PR
    Sleep; 2021 Nov; 44(11):. PubMed ID: 34115851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
    Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
    Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials.
    Mignot E; Mayleben D; Fietze I; Leger D; Zammit G; Bassetti CLA; Pain S; Kinter DS; Roth T;
    Lancet Neurol; 2022 Feb; 21(2):125-139. PubMed ID: 35065036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
    Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
    Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
    Narayan AJ; Downey LA; Rose S; Di Natale L; Hayley AC
    J Clin Sleep Med; 2024 May; 20(5):753-763. PubMed ID: 38174873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study.
    Li Y; Zhang R; Zhou Y; Bao C; Lin Z; Chen C; He J; Jin Z; Song L; Zhang M; Guo S; Jiang Y; Zhao Z
    Sleep; 2024 Feb; 47(2):. PubMed ID: 37864827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study.
    Langade D; Thakare V; Kanchi S; Kelgane S
    J Ethnopharmacol; 2021 Jan; 264():113276. PubMed ID: 32818573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
    Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study.
    Ried K; Tamanna T; Matthews S; Sali A
    J Sleep Res; 2023 Jun; 32(3):e13793. PubMed ID: 36539991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J; Pillar G; Hedner J; Polo O; Berkani O; Mangialaio S; Hmissi A; Zammit G; Hajak G
    Sleep Med; 2017 Aug; 36():86-94. PubMed ID: 28735928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study.
    Chandra Shekhar H; Joshua L; Thomas JV
    Adv Ther; 2024 Jan; 41(1):246-261. PubMed ID: 37899385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women.
    Rahman SA; Nathan MD; Wiley A; Crawford S; Cohn AY; Harder JA; Grant LK; Erickson A; Srivastava A; McCormick K; Bertisch SM; Winkelman JW; Joffe H
    Sleep; 2022 Mar; 45(3):. PubMed ID: 35022783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.
    Gooneratne NS; Gehrman P; Gurubhagavatula I; Al-Shehabi E; Marie E; Schwab R
    J Clin Sleep Med; 2010 Dec; 6(6):572-80. PubMed ID: 21206546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study.
    Langade D; Kanchi S; Salve J; Debnath K; Ambegaokar D
    Cureus; 2019 Sep; 11(9):e5797. PubMed ID: 31728244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study.
    Uchiyama M; Kambe D; Imadera Y; Kajiyama Y; Ogo H; Uchimura N
    Psychopharmacology (Berl); 2022 Jul; 239(7):2143-2154. PubMed ID: 35296912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis.
    Bhagavan C; Kung S; Doppen M; John M; Vakalalabure I; Oldfield K; Braithwaite I; Newton-Howes G
    CNS Drugs; 2020 Dec; 34(12):1217-1228. PubMed ID: 33244728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of SM-1 in a transient insomnia model.
    Dahl T; Chen LB; Zammit G; Ahmad M; Roth T
    Hum Psychopharmacol; 2019 Nov; 34(6):e2713. PubMed ID: 31837050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.